Viewing Study NCT03218995

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:08 PM
Ignite Modification Date: 2026-02-22 @ 6:46 PM
Study NCT ID: NCT03218995
Status: COMPLETED
Last Update Posted: 2021-12-09
First Post: 2017-07-09
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Eteplirsen in Young Participants With Duchenne Muscular Dystrophy (DMD) Amenable to Exon 51 Skipping
Sponsor: Sarepta Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Duchenne Muscular Dystrophy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None DMD View
None Duchenne View
None Eteplirsen View
None dystrophy View
None dystrophin View
None exon 51 View